Clinical Trials Browser

Completed × Thyroid Carcinoma, Anaplastic × Sorafenib × Clear all

NCT03565536 2024-04-19

Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer

Phase 2 Completed

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT00654238 2019-11-18

Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer

Phase 2 Completed

59 enrolled 8 charts

EndocrineHead & Neck

Thyroid Neoplasms, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic